Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sigma Pharma is a prominent Brazilian pharmaceutical division of the EMS Group, the largest pharmaceutical company in Brazil. It focuses on the ethical market, developing and commercializing prescription medications across a wide range of therapeutic areas including cardiology, gastroenterology, gynecology, and orthopedics. Headquartered in Hortolândia, São Paulo, the company leverages the extensive R&D and manufacturing infrastructure of the EMS Group to produce high-quality branded generics and innovative formulations. Sigma Pharma plays a critical role in the Brazilian healthcare system by providing accessible treatments for chronic and acute conditions. Its portfolio is supported by a large sales force that maintains direct engagement with medical professionals throughout the country.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EMS Sigma.